At a glance
ClinicalIndex Comparison RecordN/ACompleted· 650 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Association of Hepatitis C Virus Seropositivity With Breast Cancer Prognosis and Treatment Outcome
In Brief
An observational study for Breast Cancer and Hepatitis C. Completed, enrolled 650 participants across 1 site.
Detailed Summary
Hepatitis C viral infection is a major health problem in Egypt. The management of breast cancer patients is often complicated by the presence of associated HCV infection. This study aims at investigating the epidemiological association of the two conditions. It will also investigate the possible correlation with treatment outcome.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer, Hepatitis C
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartSep 2019
First PostedSep 2019
Primary CompletionJun 2020
TodayJul 2026
First PostedSep 16, 2019
Enrollment StartSep 1, 2019
Primary CompletionJun 1, 2020
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 6.8 years ago